APAC High Content Screening Market - Industry Trends and Forecast to 2030

Description

List of Tables

The Asia-Pacific high content screening market is expected to reach USD 874,587.24 thousand by 2030 from USD 459,657.52 thousand in 2022, growing at a CAGR of 8.4% during the forecast period of 2023 to 2030.

Market Segmentation

Asia-Pacific high content screening Market, By Product Type (Instruments, Consumables, Software, Services, and Accessories), Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, and Other Applications), Technology (Microscopy, Flow Cytometry, Mass Spectrometry, Western Blotting, ELISA, Immunohistochemistry, and Others), End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, Laboratories, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (Japan, China, India, South Korea, Australia, New Zealand, Singapore, Thailand, Malaysia, Vietnam, Taiwan, Indonesia, Philippines and Rest of Asia-Pacific) - Industry Trends and Forecast to 2030.

Overview of Asia-Pacific High Content Screening Market Dynamics

Driver
Increasing drug discovery and development activities
Restraint
High cost associated with initial setup and maintenance
Opportunity
The growing number of Contract Research Organizations (CROs) providing HCS services

Market Players

Some of the major market players operating in the Asia-Pacific high content screening market are:

BD
Merck KGaA
Corning Incorporated
Carl Zeiss AG
Sartorius AG
EVIDENT
Molecular Devices, LLC. (Subsidiary of Danaher Corporation)
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Yokogawa Electric Corporation
Sysmex Corporation
Genedata AG
Miltenyi Biotec

1 INTRODUCTION 33

1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.3 OVERVIEW OF THE ASIA PACIFIC HIGH CONTENT SCREENING MARKET 33
1.4 LIMITATIONS 35
1.5 MARKETS COVERED 35

2 MARKET SEGMENTATION 39

2.1 MARKETS COVERED 39
2.2 GEOGRAPHICAL SCOPE 40
2.3 YEARS CONSIDERED FOR THE STUDY 41
2.4 CURRENCY AND PRICING 41
2.5 DBMR TRIPOD DATA VALIDATION MODEL 42
2.6 MULTIVARIATE MODELLING 45
2.7 PRODUCT TYPE LIFELINE CURVE 45
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46
2.9 DBMR MARKET POSITION GRID 47
2.10 MARKET APPLICATION COVERAGE GRID 48
2.11 VENDOR SHARE ANALYSIS 49
2.12 SECONDARY SOURCES 50
2.13 ASSUMPTIONS 50

3 EXECUTIVE SUMMARY 51

4 PREMIUM INSIGHTS 53

4.1 PORTER'S FIVE FORCES MODEL 55

5 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: REGULATIONS 56

6 MARKET OVERVIEW, ASIA PACIFIC HIGH CONTENT SCREENING MARKET 58

6.1 DRIVERS 60
- 6.1.1 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH CONTENT SCREENING 60
- 6.1.2 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS 60
- 6.1.3 INCREASING RESEARCH ACTIVITIES ASSOCIATED WITH THE USAGE OF HIGH CONTENT SCREENING 61
- 6.1.4 INCREASING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 62
6.2 RESTRAINTS 62
- 6.2.1 HIGH COST ASSOCIATED WITH INITIAL SETUP AND MAINTENANCE 62
- 6.2.2 COMPLEXITY ASSOCIATED WITH CELLULAR AND MOLECULAR SAMPLES 63
6.3 OPPORTUNITIES 64
- 6.3.1 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS (CROS) PROVIDING HCS SERVICES 64
- 6.3.2 RISING INTEGRATION WITH ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DISCOVERY AND DEVELOPMENT 64
- 6.3.3 INCREASING GOVERNMENT INITIATIVE AND FUNDING IN R&D 65
6.4 CHALLENGES 65
- 6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE HCS 65
- 6.4.2 DATA SECURITY AND DATA MANAGEMENT PROBLEMS IN HCS 66

7 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE 67

7.1 OVERVIEW 68
7.2 INSTRUMENTS 71
- 7.2.1 CELL IMAGING AND ANALYSIS SYSTEM 72
  - 7.2.1.1 FIXED 72
  - 7.2.1.2 MOBILE 72
- 7.2.2 HIGH-CONTENT AND SCREENING SYSTEM 72
  - 7.2.2.1 FIXED 73
  - 7.2.2.2 MOBILE 73
- 7.2.3 FLOW CYTOMETRY 73
- 7.2.4 INVITROGEN HCA ONSTAGE INCUBATOR 73
- 7.2.5 MICROPLATE MOVER 73
- 7.2.6 OTHERS 73
7.3 SOFTWARE 73
7.4 CONSUMABLES 74
- 7.4.1 REAGENTS & ASSAY KITS 75
- 7.4.2 MICROPLATES 75
- 7.4.3 OTHERS 75
7.5 ACCESSORIES 75
7.6 SERVICES 76

8 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY APPLICATION 78

8.1 OVERVIEW 79
8.2 PRIMARY AND SECONDARY SCREENING 82
- 8.2.1 INSTRUMENTS 83
- 8.2.2 CONSUMABLES 83
- 8.2.3 ACCESSORIES 83
- 8.2.4 SERVICES 83
8.3 TARGET IDENTIFICATION AND VALIDATION 83
- 8.3.1 INSTRUMENTS 84
- 8.3.2 CONSUMABLES 84
- 8.3.3 ACCESSORIES 84
- 8.3.4 SERVICES 85
8.4 TOXICITY STUDIES 85
- 8.4.1 INSTRUMENTS 86
- 8.4.2 CONSUMABLES 86
- 8.4.3 ACCESSORIES 86
- 8.4.4 SERVICES 86
8.5 COMPOUND PROFILING 86
- 8.5.1 INSTRUMENTS 87
- 8.5.2 CONSUMABLES 87
- 8.5.3 ACCESSORIES 87
- 8.5.4 SERVICES 88
8.6 OTHER APPLICATIONS 88

9 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY 89

9.1 OVERVIEW 90
9.2 MICROSCOPY 93
9.3 FLOW CYTOMETRY 93
9.4 IMMUNOHISTOCHEMISTRY 94
9.5 MASS SPECTROMETRY 95
9.6 ELISA 96
9.7 WESTERN BLOTTING 97
9.8 OTHERS 97
- 9.8.1 3D CELL CULTURE MODEL 98
  - 9.8.1.1 STEROIDS 99
  - 9.8.1.2 ORGANOIDS 99
  - 9.8.1.3 TISSUE ON A CHIP 99
- 9.8.2 EXTRACELLULAR MATRIX BASED SCAFFOLD 99
- 9.8.3 SYNTHETIC HYDROGEL AND SCAFFOLD 99

10 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY END USER 100

10.1 OVERVIEW 101
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 104
- 10.2.1 INSTRUMENTS 104
- 10.2.2 CONSUMABLES 105
- 10.2.3 ACCESSORIES 105
- 10.2.4 SERVICES 105
10.3 CONTRACT RESEARCH ORGANIZATIONS 105
- 10.3.1 INSTRUMENTS 106
- 10.3.2 CONSUMABLES 106
- 10.3.3 ACCESSORIES 106
- 10.3.4 SERVICES 106
10.4 LABORATORIES 107
- 10.4.1 INSTRUMENTS 108
- 10.4.2 CONSUMABLES 108
- 10.4.3 ACCESSORIES 108
- 10.4.4 SERVICES 108
10.5 ACADEMIC AND GOVERNMENT INSTITUTES 108
- 10.5.1 INSTRUMENTS 109
- 10.5.2 CONSUMABLES 109
- 10.5.3 ACCESSORIES 109
- 10.5.4 SERVICES 109
10.6 OTHERS 110

11 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL 111

11.1 OVERVIEW 112
11.2 DIRECT TENDERS 115
11.3 RETAIL SALES 115

12 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY REGION 117

12.1 ASIA-PACIFIC 118
- 12.1.1 JAPAN 130
- 12.1.2 CHINA 137
- 12.1.3 INDIA 144
- 12.1.4 SOUTH KOREA 151
- 12.1.5 AUSTRALIA 158
- 12.1.6 NEW ZEALAND 165
- 12.1.7 SINGAPORE 172
- 12.1.8 THAILAND 179
- 12.1.9 MALAYSIA 186
- 12.1.10 VIETNAM 193
- 12.1.11 TAIWAN 200
- 12.1.12 INDONESIA 207
- 12.1.13 PHILIPPINES 214
- 12.1.14 REST OF ASIA-PACIFIC 221

13 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, COMPANY LANDSCAPE 222

13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 222

14 ASIA PACIFIC CONTENT SCREENING MARKET, COMPANY PROFILES 223

14.1 THERMO FISHER SCIENTIFIC INC. (2022) 223
- 14.1.1 COMPANY SNAPSHOT 223
- 14.1.2 REVENUE ANALYSIS 223
- 14.1.3 COMPANY SHARE ANALYSIS 224
- 14.1.4 PRODUCT PORTFOLIO 224
- 14.1.5 RECENT DEVELOPMENT 224
14.2 BD 225
- 14.2.1 COMPANY SNAPSHOT 225
- 14.2.2 REVENUE ANALYSIS 225
- 14.2.3 COMPANY SHARE ANALYSIS 226
- 14.2.4 PRODUCT PORTFOLIO 226
- 14.2.5 RECENT DEVELOPMENTS 226
14.3 PERKINELMER INC. (2022) 227
- 14.3.1 COMPANY SNAPSHOT 227
- 14.3.2 REVENUE ANALYSIS 227
- 14.3.3 COMPANY SHARE ANALYSIS 228
- 14.3.4 PRODUCT PORTFOLIO 228
- 14.3.5 RECENT DEVELOPMENTS 229
14.4 YOKOGAWA ELECTRIC CORPORATION (2022) 230
- 14.4.1 COMPANY SNAPSHOT 230
- 14.4.2 REVENUE ANALYSIS 230
- 14.4.3 COMPANY SHARE ANALYSIS 231
- 14.4.4 PRODUCT PORTFOLIO 231
- 14.4.5 RECENT DEVELOPMENT 231
14.5 MOLECULAR DEVICES, LLC. (A SUBSIDIARY OF DANAHER CORPORATION) 232
- 14.5.1 COMPANY SNAPSHOT 232
- 14.5.2 REVENUE ANALYSIS 232
- 14.5.3 COMPANY SHARE ANALYSIS 233
- 14.5.4 PRODUCT PORTFOLIO 233
- 14.5.5 RECENT DEVELOPMENT 234
14.6 AGILENT TECHNOLOGIES, INC. (2022) 235
- 14.6.1 COMPANY SNAPSHOT 235
- 14.6.2 REVENUE ANALYSIS 235
- 14.6.3 PRODUCT PORTFOLIO 236
- 14.6.4 RECENT DEVELOPMENT 236
14.7 ALIGNED GENETICS, INC. (2022) 237
- 14.7.1 COMPANY SNAPSHOT 237
- 14.7.2 REVENUE ANALYSIS 237
- 14.7.3 PRODUCT PORTFOLIO 238
- 14.7.4 RECENT DEVELOPMENT 238
14.8 ARACELI BIOSCIENCES 239
- 14.8.1 COMPANY SNAPSHOT 239
- 14.8.2 PRODUCT PORTFOLIO 239
- 14.8.3 RECENT DEVELOPMENT 239
14.9 AXXAM S.P.A 240
- 14.9.1 COMPANY SNAPSHOT 240
- 14.9.2 PRODUCT PORTFOLIO 240
- 14.9.3 RECENT DEVELOPMENT 240
14.10 BIO-RAD LABORATORIES, INC. (2022) 241
- 14.10.1 COMPANY SNAPSHOT 241
- 14.10.2 REVENUE ANALYSIS 241
- 14.10.3 PRODUCT PORTFOLIO 242
- 14.10.4 RECENT DEVELOPMENTS 242
14.11 CARL ZEISS AG 243
- 14.11.1 COMPANY SNAPSHOT 243
- 14.11.2 REVENUE ANALYSIS 243
- 14.11.3 PRODUCT PORTFOLIO 244
- 14.11.4 RECENT DEVELOPMENT 244
14.12 CORNING INCORPORATED 245
- 14.12.1 COMPANY SNAPSHOT 245
- 14.12.2 REVENUE ANALYSIS 245
- 14.12.3 PRODUCT PORTFOLIO 246
- 14.12.4 RECENT DEVELOPMENT 246
14.13 DE NOVO SOFTWARE 247
- 14.13.1 COMPANY SNAPSHOT 247
- 14.13.2 PRODUCT PORTFOLIO 247
- 14.13.3 RECENT DEVELOPMENTS 247
14.14 EVIDENT 248
- 14.14.1 COMPANY SNAPSHOT 248
- 14.14.2 PRODUCT PORTFOLIO 248
- 14.14.3 RECENT DEVELOPMENT 248
14.15 GENEDATA AG 249
- 14.15.1 COMPANY SNAPSHOT 249
- 14.15.2 PRODUCT PORTFOLIO 249
- 14.15.3 RECENT DEVELOPMENT 249
14.16 MERCK KGAA 250
- 14.16.1 COMPANY SNAPSHOT 250
- 14.16.2 REVENUE ANALYSIS 250
- 14.16.3 PRODUCT PORTFOLIO 251
- 14.16.4 RECENT DEVELOPMENTS 251
14.17 MILTENYI BIOTEC 252
- 14.17.1 COMPANY SNAPSHOT 252
- 14.17.2 PRODUCT PORTFOLIO 252
- 14.17.3 RECENT DEVELOPMENT 253
14.18 SARTORIUS AG 254
- 14.18.1 COMPANY SNAPSHOT 254
- 14.18.2 REVENUE ANALYSIS 254
- 14.18.3 PRODUCT PORTFOLIO 255
- 14.18.4 RECENT DEVELOPMENTS 255
14.19 SYSMEX CORPORATION 256
- 14.19.1 COMPANY SNAPSHOT 256
- 14.19.2 REVENUE ANALYSIS 256
- 14.19.3 PRODUCT PORTFOLIO 257
- 14.19.4 RECENT DEVELOPMENT 257
14.20 ZIFO RND SOLUTIONS 258
- 14.20.1 COMPANY SNAPSHOT 258
- 14.20.2 PRODUCT PORTFOLIO 258
- 14.20.3 RECENT DEVELOPMENTS 258

15 QUESTIONNAIRE 259

16 RELATED REPORTS 263

LIST OF TABLES

TABLE 1 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 64
TABLE 2 ASIA PACIFIC INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 65
TABLE 3 ASIA PACIFIC INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 66
TABLE 4 ASIA PACIFIC CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 66
TABLE 5 ASIA PACIFIC HIGH-CONTENT AND SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 67
TABLE 6 ASIA PACIFIC SOFTWARES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
TABLE 7 ASIA PACIFIC CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
TABLE 8 ASIA PACIFIC CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 69
TABLE 9 ASIA PACIFIC ACCESSORIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
TABLE 10 ASIA PACIFIC SERVICES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 71
TABLE 11 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 75
TABLE 12 ASIA PACIFIC PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
TABLE 13 ASIA PACIFIC PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 77
TABLE 14 ASIA PACIFIC TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 78
TABLE 15 ASIA PACIFIC TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 78
TABLE 16 ASIA PACIFIC TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
TABLE 17 ASIA PACIFIC TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 80
TABLE 18 ASIA PACIFIC COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
TABLE 19 ASIA PACIFIC COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 81
TABLE 20 ASIA PACIFIC OTHER APPLICATION IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
TABLE 21 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 86
TABLE 22 ASIA PACIFIC MICROSCOPY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
TABLE 23 ASIA PACIFIC FLOW CYTOMETRY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 88
TABLE 24 ASIA PACIFIC IMMUNOHISTOCHEMISTRY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 89
TABLE 25 ASIA PACIFIC MASS SPECTROSCOPY IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 90
TABLE 26 ASIA PACIFIC ELISA IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 90
TABLE 27 ASIA PACIFIC WESTERN BLOTTING IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 91
TABLE 28 ASIA PACIFIC OTHERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 92
TABLE 29 ASIA PACIFIC OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 92
TABLE 30 ASIA PACIFIC 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 93
TABLE 31 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 97
TABLE 32 ASIA PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
TABLE 33 ASIA PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 98
TABLE 34 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
TABLE 35 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 100
TABLE 36 ASIA PACIFIC LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 101
TABLE 37 ASIA PACIFIC LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 101
TABLE 38 ASIA PACIFIC ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 103
TABLE 39 ASIA PACIFIC ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 103
TABLE 40 ASIA PACIFIC OTHERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 104
TABLE 41 ASIA PACIFIC HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 108
TABLE 42 ASIA PACIFIC DIRECT TENDERS IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 109
TABLE 43 ASIA PACIFIC RETAIL SALES IN HIGH CONTENT SCREENING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 110
TABLE 44 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 116
TABLE 45 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
TABLE 46 ASIA-PACIFIC INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
TABLE 47 ASIA-PACIFIC CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
TABLE 48 ASIA-PACIFIC HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 49 ASIA-PACIFIC CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 50 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 118
TABLE 51 ASIA-PACIFIC PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 52 ASIA-PACIFIC TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 53 ASIA-PACIFIC TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 54 ASIA-PACIFIC COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 55 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 120
TABLE 56 ASIA-PACIFIC OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 120
TABLE 57 ASIA-PACIFIC 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 121
TABLE 58 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 121
TABLE 59 ASIA-PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
TABLE 60 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 61 ASIA-PACIFIC LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 62 ASIA-PACIFIC ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 63 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 123
TABLE 64 JAPAN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 65 JAPAN INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 66 JAPAN CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 67 JAPAN HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 68 JAPAN CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 69 JAPAN HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 126
TABLE 70 JAPAN PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 71 JAPAN TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 72 JAPAN TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 73 JAPAN COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 74 JAPAN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 127
TABLE 75 JAPAN OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 128
TABLE 76 JAPAN 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 128
TABLE 77 JAPAN HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 128
TABLE 78 JAPAN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 79 JAPAN CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 80 JAPAN LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 81 JAPAN ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 82 JAPAN HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 130
TABLE 83 CHINA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
TABLE 84 CHINA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
TABLE 85 CHINA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 86 CHINA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 87 CHINA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 88 CHINA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 133
TABLE 89 CHINA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 90 CHINA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 91 CHINA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 92 CHINA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 93 CHINA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 134
TABLE 94 CHINA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 135
TABLE 95 CHINA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 135
TABLE 96 CHINA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 135
TABLE 97 CHINA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 98 CHINA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 99 CHINA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 100 CHINA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
TABLE 101 CHINA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 137
TABLE 102 INDIA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 103 INDIA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 104 INDIA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 105 INDIA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 106 INDIA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 107 INDIA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 139
TABLE 108 INDIA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 109 INDIA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 110 INDIA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 111 INDIA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
TABLE 112 INDIA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 141
TABLE 113 INDIA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 141
TABLE 114 INDIA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 142
TABLE 115 INDIA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 142
TABLE 116 INDIA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 142
TABLE 117 INDIA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 118 INDIA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 119 INDIA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 120 INDIA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 144
TABLE 121 SOUTH KOREA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 122 SOUTH KOREA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 123 SOUTH KOREA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 124 SOUTH KOREA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 125 SOUTH KOREA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 126 SOUTH KOREA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 147
TABLE 127 SOUTH KOREA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 147
TABLE 128 SOUTH KOREA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 147
TABLE 129 SOUTH KOREA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 130 SOUTH KOREA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 131 SOUTH KOREA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 149
TABLE 132 SOUTH KOREA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 149
TABLE 133 SOUTH KOREA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 149
TABLE 134 SOUTH KOREA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 150
TABLE 135 SOUTH KOREA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 136 SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 137 SOUTH KOREA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 138 SOUTH KOREA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 139 SOUTH KOREA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 151
TABLE 140 AUSTRALIA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
TABLE 141 AUSTRALIA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
TABLE 142 AUSTRALIA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
TABLE 143 AUSTRALIA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
TABLE 144 AUSTRALIA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
TABLE 145 AUSTRALIA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 154
TABLE 146 AUSTRALIA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 147 AUSTRALIA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 148 AUSTRALIA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 149 AUSTRALIA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 150 AUSTRALIA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 156
TABLE 151 AUSTRALIA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 156
TABLE 152 AUSTRALIA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 156
TABLE 153 AUSTRALIA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 157

TABLE 154 AUSTRALIA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
TABLE 155 AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
TABLE 156 AUSTRALIA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
TABLE 157 AUSTRALIA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
TABLE 158 AUSTRALIA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 158
TABLE 159 NEW ZEALAND HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
TABLE 160 NEW ZEALAND INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
TABLE 161 NEW ZEALAND CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 162 NEW ZEALAND HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 163 NEW ZEALAND CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 164 NEW ZEALAND HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 161
TABLE 165 NEW ZEALAND PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 166 NEW ZEALAND TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 167 NEW ZEALAND TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 168 NEW ZEALAND COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 169 NEW ZEALAND HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 163
TABLE 170 NEW ZEALAND OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 163
TABLE 171 NEW ZEALAND 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 163
TABLE 172 NEW ZEALAND HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 164
TABLE 173 NEW ZEALAND PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 174 NEW ZEALAND CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 175 NEW ZEALAND LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 176 NEW ZEALAND ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 177 NEW ZEALAND HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 165
TABLE 178 SINGAPORE HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 179 SINGAPORE INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 180 SINGAPORE CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
TABLE 181 SINGAPORE HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
TABLE 182 SINGAPORE CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
TABLE 183 SINGAPORE HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 168
TABLE 184 SINGAPORE PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
TABLE 185 SINGAPORE TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
TABLE 186 SINGAPORE TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 187 SINGAPORE COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 188 SINGAPORE HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 170
TABLE 189 SINGAPORE OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 170
TABLE 190 SINGAPORE 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 170
TABLE 191 SINGAPORE HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 171
TABLE 192 SINGAPORE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
TABLE 193 SINGAPORE CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
TABLE 194 SINGAPORE LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
TABLE 195 SINGAPORE ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
TABLE 196 SINGAPORE HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 172
TABLE 197 THAILAND HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
TABLE 198 THAILAND INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 173
TABLE 199 THAILAND CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
TABLE 200 THAILAND HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
TABLE 201 THAILAND CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 174
TABLE 202 THAILAND HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 175
TABLE 203 THAILAND PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 204 THAILAND TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 205 THAILAND TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 206 THAILAND COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 207 THAILAND HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 177
TABLE 208 THAILAND OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 177
TABLE 209 THAILAND 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 177
TABLE 210 THAILAND HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 178
TABLE 211 THAILAND PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 178
TABLE 212 THAILAND CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 178
TABLE 213 THAILAND LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
TABLE 214 THAILAND ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 179
TABLE 215 THAILAND HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 179
TABLE 216 MALAYSIA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
TABLE 217 MALAYSIA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 180
TABLE 218 MALAYSIA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
TABLE 219 MALAYSIA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
TABLE 220 MALAYSIA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 181
TABLE 221 MALAYSIA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 182
TABLE 222 MALAYSIA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
TABLE 223 MALAYSIA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
TABLE 224 MALAYSIA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 183
TABLE 225 MALAYSIA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 183
TABLE 226 MALAYSIA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 184
TABLE 227 MALAYSIA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 184
TABLE 228 MALAYSIA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 184
TABLE 229 MALAYSIA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 185
TABLE 230 MALAYSIA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 185
TABLE 231 MALAYSIA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 185
TABLE 232 MALAYSIA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
TABLE 233 MALAYSIA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 186
TABLE 234 MALAYSIA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 186
TABLE 235 VIETNAM HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
TABLE 236 VIETNAM INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 187
TABLE 237 VIETNAM CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 188
TABLE 238 VIETNAM HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 188
TABLE 239 VIETNAM CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 188
TABLE 240 VIETNAM HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 189
TABLE 241 VIETNAM PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
TABLE 242 VIETNAM TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
TABLE 243 VIETNAM TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 190
TABLE 244 VIETNAM COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 190
TABLE 245 VIETNAM HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 191
TABLE 246 VIETNAM OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 191
TABLE 247 VIETNAM 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 191
TABLE 248 VIETNAM HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 192
TABLE 249 VIETNAM PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 192
TABLE 250 VIETNAM CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 192
TABLE 251 VIETNAM LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 193
TABLE 252 VIETNAM ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 193
TABLE 253 VIETNAM HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 193
TABLE 254 TAIWAN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
TABLE 255 TAIWAN INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 194
TABLE 256 TAIWAN CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 195
TABLE 257 TAIWAN HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 195
TABLE 258 TAIWAN CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 195
TABLE 259 TAIWAN HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 196
TABLE 260 TAIWAN PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
TABLE 261 TAIWAN TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
TABLE 262 TAIWAN TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
TABLE 263 TAIWAN COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
TABLE 264 TAIWAN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 198
TABLE 265 TAIWAN OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 198
TABLE 266 TAIWAN 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 198
TABLE 267 TAIWAN HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 199
TABLE 268 TAIWAN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 199
TABLE 269 TAIWAN CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 199
TABLE 270 TAIWAN LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 200
TABLE 271 TAIWAN ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 200
TABLE 272 TAIWAN HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 200
TABLE 273 INDONESIA HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 201
TABLE 274 INDONESIA INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 201
TABLE 275 INDONESIA CELL IMAGING AND ANALYSIS SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 202
TABLE 276 INDONESIA HIGH-CONTENT SCREENING SYSTEM IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 202
TABLE 277 INDONESIA CONSUMABLES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 202
TABLE 278 INDONESIA HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 203
TABLE 279 INDONESIA PRIMARY AND SECONDARY SCREENING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 203
TABLE 280 INDONESIA TARGET IDENTIFICATION & VALIDATION IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 203
TABLE 281 INDONESIA TOXICITY STUDIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 204
TABLE 282 INDONESIA COMPOUND PROFILING IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 204
TABLE 283 INDONESIA HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 205
TABLE 284 INDONESIA OTHERS IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 205
TABLE 285 INDONESIA 3D CELL CULTURE MODEL IN HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND) 205
TABLE 286 INDONESIA HIGH CONTENT SCREENING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 206
TABLE 287 INDONESIA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 206
TABLE 288 INDONESIA CONTRACT RESEARCH ORGANIZATIONS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 206
TABLE 289 INDONESIA LABORATORIES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 207
TABLE 290 INDONESIA ACADEMIC AND GOVERNMENT INSTITUTES IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 207
TABLE 291 INDONESIA HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 207
TABLE 292 PHILIPPINES HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 208
TABLE 293 PHILIPPINES INSTRUMENTS IN HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 208

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: SEGMENTATION 33
FIGURE 2 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: DATA TRIANGULATION 36
FIGURE 3 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: DROC ANALYSIS 37
FIGURE 4 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 38
FIGURE 5 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: COMPANY RESEARCH ANALYSIS 38
FIGURE 6 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: INTERVIEW DEMOGRAPHICS 40
FIGURE 7 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: DBMR MARKET POSITION GRID 41
FIGURE 8 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: MARKET APPLICATION COVERAGE GRID 42
FIGURE 9 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: VENDOR SHARE ANALYSIS 43
FIGURE 10 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: SEGMENTATION 46
FIGURE 11 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH-CONTENT SCREENING IS EXPECTED TO DRIVE THE GROWTH OF THE ASIA PACIFIC HIGH CONTENT SCREENING MARKET IN THE FORECAST PERIOD 47
FIGURE 12 THE PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC HIGH CONTENT SCREENING MARKET IN 2023 AND 2030 47
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC HIGH CONTENT SCREENING MARKET 53
FIGURE 14 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, 2022 62
FIGURE 15 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, 2023-2030 (USD THOUSAND) 63
FIGURE 16 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 63
FIGURE 17 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE, LIFELINE CURVE 64
FIGURE 18 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY APPLICATION, 2022 73
FIGURE 19 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 74
FIGURE 20 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY APPLICATION, CAGR (2023-2030) 74
FIGURE 21 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY APPLICATION, LIFELINE CURVE 75
FIGURE 22 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, 2022 84
FIGURE 23 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, 2023-2030 (USD THOUSAND) 85
FIGURE 24 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, CAGR (2023-2030) 85
FIGURE 25 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY TECHNOLOGY, LIFELINE CURVE 86
FIGURE 26 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY END USER, 2022 95
FIGURE 27 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY END USER, 2023-2030 (USD THOUSAND) 96
FIGURE 28 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY END USER, CAGR (2023-2030) 96
FIGURE 29 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY END USER, LIFELINE CURVE 97
FIGURE 30 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2022 106
FIGURE 31 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 107
FIGURE 32 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 107
FIGURE 33 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 108
FIGURE 34 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: SNAPSHOT (2022) 113
FIGURE 35 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022) 114
FIGURE 36 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: BY COUNTRY (2023 & 2030) 114
FIGURE 37 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: BY COUNTRY (2022 & 2030) 115
FIGURE 38 ASIA-PACIFIC HIGH CONTENT SCREENING MARKET: BY PRODUCT TYPE (2023-2030) 115
FIGURE 39 ASIA PACIFIC HIGH CONTENT SCREENING MARKET: COMPANY SHARE 2022 (%) 216